BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,244,411 | -8.6% | 176,763 | +8.3% | 0.00% | -50.0% |
| Q1 2023 | $1,360,779 | -41.8% | 163,163 | -19.9% | 0.00% | -33.3% |
| Q4 2022 | $2,337,718 | +48.3% | 203,634 | +62.8% | 0.00% | +50.0% |
| Q3 2022 | $1,576,000 | -47.7% | 125,068 | -56.1% | 0.00% | -50.0% |
| Q2 2022 | $3,014,000 | +5.9% | 284,851 | +62.8% | 0.00% | +33.3% |
| Q1 2022 | $2,846,000 | -32.8% | 175,017 | -42.8% | 0.00% | -25.0% |
| Q4 2021 | $4,235,000 | +19.6% | 305,751 | +24.1% | 0.00% | 0.0% |
| Q3 2021 | $3,541,000 | -35.4% | 246,446 | -28.9% | 0.00% | -33.3% |
| Q2 2021 | $5,483,000 | +2816.5% | 346,833 | +598.3% | 0.01% | – |
| Q2 2019 | $188,000 | – | 49,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |